Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm, primary central nervous system lymphoma, refractory malignant neoplasm	Recruiting	Phase 2	2026-03-03		NCT05681195

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baptist Health South Florida	26
BeiGene	47

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Miami Cancer Institute at Baptist Health, Inc.	Miami	United States	22

Clinical trials